- Report
- October 2026
- 225 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 381 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 266 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 404 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 192 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 194 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 184 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 236 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 201 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 247 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 187 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 506 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 230 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 505 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 204 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 194 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 220 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 179 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 200 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 188 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more